Published in AIDS Weekly, June 3rd, 2002
The tampering could be dangerous, manufacturer GlaxoSmithKline warned May 10, 2002.
About 5% of people who take Ziagen can suffer potentially life-threatening allergic reactions - something patients thinking they were taking Combivir wouldn't have been warned about since that drug doesn't carry the same risk, the company said.
Another problem: Combivir provides HIV patients with two antiviral medications...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2002-06-03)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.